NIMOTOP Side Effects

6977291-6 | Syncope
on Sep 06, 2010 Female patient from ITALY , 81 years of age, was diagnosed with hypertension and was treated with Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: syncope. Nimotop dosage: . During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), SOTALEX (View Sotalex Review and Sotalex Label ), PLACTIDIL (View Plactidil Review and Plactidil Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), FLIXOTIDE (View Flixotide Review and Flixotide Label ). Patient was hospitalized.

6878988-9 | Hypotension, Malaise, Syncope
Patient was taking Nimotop (View Usage). Patient had the following side effects: hypotension, malaise, syncope on Jul 20, 2010 from ITALY Additional patient health information: Female patient , 88 years of age, was diagnosed with hypertension and. Nimotop dosage: As Used: 30/0.75 Mg/ml. During the same period patient was treated with ZESTORETIC (View Zestoretic Review and Zestoretic Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6786713-5 | Hypotension, Malaise, Syncope
Adverse event was reported on Jun 01, 2010 by a Female patient taking Nimotop (View Usage) (Dosage: As Used: 30/0.75 Mg/ml) was diagnosed with hypertension and. Location: ITALY , 88 years of age, After Nimotop was administered, patient had the following side effects: hypotension, malaise, syncope. During the same period patient was treated with ZESTORETIC (View Zestoretic Review and Zestoretic Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PARIET (View Pariet Review and Pariet Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

6772206-8 | Hypotension, Malaise, Syncope
on Jun 01, 2010 Female patient from ITALY , 88 years of age, was diagnosed with hypertension and was treated with Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, malaise, syncope. Nimotop dosage: As Used: 30/0.75 Mg/ml. During the same period patient was treated with ZESTORETIC (View Zestoretic Review and Zestoretic Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PARIET (View Pariet Review and Pariet Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.


6605244-6 | Respiratory Failure
on Jan 14, 2010 Female patient from BRAZIL , 95 years of age, weighting 103.6 lb, was diagnosed with memory impairment and was treated with Nimotop (View Usage). Patient had the following side effects: respiratory failure. Nimotop dosage: Total Daily Dose: 60 Mg Unit Dose: 30 Mg. During the same period patient was treated with ANCORON (1 Tablet At Morning) (View Ancoron Review and Ancoron Label ), SUSTRATE (View Sustrate Review and Sustrate Label ), MAREVAN (View Marevan Review and Marevan Label ), DAFLON (View Daflon Review and Daflon Label ). Patient was hospitalized.

6570016-8 | Respiratory Failure
Patient was taking Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: respiratory failure on Jan 14, 2010 from BRAZIL Additional patient health information: Female patient , 95 years of age, weighting 103.6 lb, was diagnosed with memory impairment and. Nimotop dosage: Total Daily Dose: 60 Mg Unit Dose: 30 Mg. During the same period patient was treated with ANCORON (1 Tablet At Morning) (View Ancoron Review and Ancoron Label ), SUSTRATE (View Sustrate Review and Sustrate Label ), MAREVAN (View Marevan Review and Marevan Label ), DAFLON (View Daflon Review and Daflon Label ). Patient was hospitalized.

6377475-4 | Anxiety, Pyrexia, Tracheostomy
Adverse event was reported on Sep 17, 2009 by a Male patient taking Nimotop (View Usage) (Dosage: 10 Ml/h) was diagnosed with subarachnoid haemorrhage, alcohol abuse and. Location: SWEDEN , 46 years of age, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), pyrexia, tracheostomy. During the same period patient was treated with ANTABUSE (View Antabuse Review and Antabuse Label ).

6302642-5 | Bradycardia, Chest Discomfort, Hypotension, Nervousness, Palpitations
on Aug 05, 2009 Male patient from CHINA , 82 years of age, was diagnosed with cerebral infarction and was treated with Nimotop (View Usage). Patient had the following side effects: bradycardia, chest discomfort, hypotension, nervousness, palpitations. Nimotop dosage: Unit Dose: 50 Ml.

6294473-X | Bradycardia, Chest Discomfort, Hypotension, Nervousness
on Apr 08, 2009 Male patient from CHINA , 82 years of age, was diagnosed with cerebral infarction and was treated with Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: bradycardia, chest discomfort, hypotension, nervousness. Nimotop dosage: Unit Dose: 50 Ml.

6292543-3 | Bradycardia, Chest Discomfort, Hypotension, Nervousness
Patient was taking Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, chest discomfort, hypotension, nervousness on Apr 08, 2009 from CHINA Additional patient health information: Male patient , 82 years of age, was diagnosed with cerebral infarction and. Nimotop dosage: Unit Dose: 50 Ml.

6282247-5 | Angioedema, Face Oedema
Adverse event was reported on Jul 17, 2009 by a Female patient taking Nimotop (View Usage) (Dosage: Total Daily Dose: 12 Df) was diagnosed with pain (What is pain?), gastroduodenal ulcer, dyslipidaemia, insomnia, anaemia, constipation (What is constipation?) and. Location: FRANCE , 77 years of age, Patient had the following side effects: angioedema, face oedema. During the same period patient was treated with DOLIPRANE (Total Daily Dose: 2000 Mg) (View Doliprane Review and Doliprane Label ), OGASTORO (Total Daily Dose: 1 Df) (View Ogastoro Review and Ogastoro Label ), ELISOR (Total Daily Dose: 40 Mg Unit Dose: 40 Mg) (View Elisor Review and Elisor Label ), LOVENOX (4000/0.4 Iu/ml / 1 Df A Day) (View Lovenox Review and Lovenox Label ), IMOVANE (Total Daily Dose: 7.5 Mg Unit Dose: 7.5 Mg) (View Imovane Review and Imovane Label ), SPECIAFOLDINE (Total Daily Dose: 1 Df) (View Speciafoldine Review and Speciafoldine Label ), POLYETHYLENE GLYCOL (Total Daily Dose: 1 Df) (View Polyethylene Glycol Review and Polyethylene Glycol Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ).

6213449-1 | Conjunctival Hyperaemia, Dysphasia, Dysphoria, Dyspnoea, Flushing, Heart Rate Increased, Hypotension, Restlessness
on May 14, 2009 Female patient from CHINA , 72 years of age, was diagnosed with dementia (What is dementia?) and was treated with Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: conjunctival hyperaemia, dysphasia, dysphoria, dyspnoea, flushing, heart rate increased, hypotension, restlessness. Nimotop dosage: Total Daily Dose: 1500 Mg Unit Dose: 30 Mg. Patient was hospitalized.

6201108-0 | Conjunctival Hyperaemia, Dysphasia, Dysphoria, Dyspnoea, Flushing, Heart Rate Increased, Hypotension, Restlessness
on May 14, 2009 Female patient from CHINA , 72 years of age, was diagnosed with dementia (What is dementia?) and was treated with Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctival hyperaemia, dysphasia, dysphoria, dyspnoea, flushing, heart rate increased, hypotension, restlessness. Nimotop dosage: Total Daily Dose: 1500 Mg Unit Dose: 30 Mg. Patient was hospitalized.

6173808-2 | Dysphasia, Flushing, Heart Rate Increased, Hypotension, Restlessness
Patient was taking Nimotop (View Usage). Patient had the following side effects: dysphasia, flushing, heart rate increased, hypotension, restlessness on Apr 27, 2009 from CHINA Additional patient health information: Female patient , 72 years of age, was diagnosed with depression (What is depression?) and. Nimotop dosage: Unit Dose: 30 Mg.

5906008-9 | Toxic Epidermal Necrolysis
Adverse event was reported on Sep 26, 2008 by a Female patient taking Nimotop (View Usage) (Dosage: ) . Location: FRANCE , 49 years of age, After Nimotop was administered, patient had the following side effects: toxic epidermal necrolysis. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), TAHOR (View Tahor Review and Tahor Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), SUFENTA PRESERVATIVE FREE (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ), LOXEN (View Loxen Review and Loxen Label ), EUPRESSYL (View Eupressyl Review and Eupressyl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

5804675-1 | Hyperpyrexia, Pleural Effusion
on Jul 07, 2008 Female patient from CHINA , 70 years of age, was diagnosed with subarachnoid haemorrhage and was treated with Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: hyperpyrexia, pleural effusion. Nimotop dosage: Total Daily Dose: 10 Mg Unit Dose: 10 Mg.

5771140-X | Bradycardia, Cardio-respiratory Arrest
on Dec 11, 2006 Female patient from UNITED STATES , 55 years of age, was diagnosed with subarachnoid haemorrhage and was treated with Nimotop (View Usage). Patient had the following side effects: bradycardia, cardio-respiratory arrest. Nimotop dosage: As Used: 60 Mg Unit Dose: 30 Mg.

5678016-7 | Ill-defined Disorder
Patient was taking Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: ill-defined disorder on Mar 24, 2008 from UNITED STATES Additional patient health information: Female patient , 65 years of age, was diagnosed with subarachnoid haemorrhage and. Nimotop dosage: 60mg Q4h Po. Patient was hospitalized.

5429280-0 | Altered State Of Consciousness, Blood Pressure Fluctuation, Headache, Nausea, Pyrexia
Adverse event was reported on Aug 28, 2007 by a Female patient taking Nimotop (View Usage) (Dosage: ) was diagnosed with cerebral haemorrhage and. Location: CHINA , 80 years of age, Patient experienced the following unwanted or unexpected effects: altered state of consciousness, blood pressure fluctuation, headache (What is headache?), nausea (What is nausea?), pyrexia. Patient was hospitalized.

5423777-5 | Chills, Pyrexia, Respiratory Failure
on Aug 21, 2007 Male patient from CHINA , 49 years of age, was diagnosed with cerebral haemorrhage and was treated with Nimotop (View Usage). Patient had the following side effects: chills, pyrexia, respiratory failure. Nimotop dosage: .

5403939-3 | Altered State Of Consciousness, Blood Pressure Fluctuation, Headache, Nausea, Pyrexia
on Jul 26, 2007 Female patient from CHINA , 80 years of age, was diagnosed with cerebral haemorrhage and was treated with Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: altered state of consciousness, blood pressure fluctuation, headache (What is headache?), nausea (What is nausea?), pyrexia. Nimotop dosage: . Patient was hospitalized.

5402143-2 | Blood Pressure Decreased, Heart Rate Decreased
Patient was taking Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, heart rate decreased on Jul 27, 2007 from UNITED STATES Additional patient health information: Female patient , 38 years of age, was diagnosed with subarachnoid haemorrhage and. Nimotop dosage: . During the same period patient was treated with NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), MANNITOL (View Mannitol Review and Mannitol Label ), ALBUMIN (HUMAN) (View Albumin (human) Review and Albumin (human) Label ). Patient was hospitalized.

5350511-X | Blood Pressure Decreased, Head Injury, Headache, Loss Of Consciousness
Adverse event was reported on Jun 05, 2007 by a Female patient taking Nimotop (View Usage) (Dosage: ) was diagnosed with brain operation and. Location: UNITED STATES , 49 years of age, weighting 145.5 lb, Patient had the following side effects: blood pressure decreased, head injury, headache (What is headache?), loss of consciousness. During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ).

5323535-6 | Blood Pressure Decreased, Head Injury, Headache, Loss Of Consciousness
on May 10, 2007 Female patient from UNITED STATES , 49 years of age, weighting 145.5 lb, was diagnosed with brain operation and was treated with Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: blood pressure decreased, head injury, headache (What is headache?), loss of consciousness. Nimotop dosage: . During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ).

5302974-3 | Blood Pressure Decreased, Head Injury, Headache, Loss Of Consciousness
on Apr 13, 2007 Female patient from UNITED STATES , 49 years of age, weighting 145.5 lb, was diagnosed with brain operation and was treated with Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, head injury, headache (What is headache?), loss of consciousness. Nimotop dosage: . During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ).

5293301-9 | Blood Pressure Decreased, Head Injury, Headache, Loss Of Consciousness
Patient was taking Nimotop (View Usage). Patient had the following side effects: blood pressure decreased, head injury, headache (What is headache?), loss of consciousness on Apr 03, 2007 from UNITED STATES Additional patient health information: Female patient , 49 years of age, weighting 145.5 lb, was diagnosed with brain operation and. Nimotop dosage: . During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ).

5214040-6 | Blood Pressure Decreased, Head Injury, Headache, Loss Of Consciousness
Adverse event was reported on Jan 10, 2007 by a Female patient taking Nimotop (View Usage) (Dosage: ) . Location: UNITED STATES , 49 years of age, After Nimotop was administered, patient had the following side effects: blood pressure decreased, head injury, headache (What is headache?), loss of consciousness. During the same period patient was treated with DILANTIN (View Dilantin Review and Dilantin Label ).

5211650-7 | Bradycardia, Cardio-respiratory Arrest
on Jan 15, 2007 Female patient from UNITED STATES , 62 years of age, was diagnosed with subarachnoid haemorrhage and was treated with Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardio-respiratory arrest. Nimotop dosage: . During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), PROPOFOL (View Propofol Review and Propofol Label ).

5173308-2 | Bradycardia, Cardio-respiratory Arrest
on Nov 20, 2006 Female patient from UNITED STATES , 62 years of age, was diagnosed with subarachnoid haemorrhage and was treated with Nimotop (View Usage). Patient had the following side effects: bradycardia, cardio-respiratory arrest. Nimotop dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), PROPOFOL (View Propofol Review and Propofol Label ).

5173307-0 | Bradycardia, Cardio-respiratory Arrest
Patient was taking Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: bradycardia, cardio-respiratory arrest on Nov 30, 2006 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with subarachnoid haemorrhage and. Nimotop dosage: As Used: 60 Mg Unit Dose: 30 Mg.

5168750-X | Bradycardia, Cardio-respiratory Arrest
Adverse event was reported on Nov 30, 2006 by a Female patient taking Nimotop (View Usage) (Dosage: As Used: 60 Mg Unit Dose: 30 Mg) was diagnosed with subarachnoid haemorrhage and. Location: UNITED STATES , 55 years of age, Patient experienced the following unwanted or unexpected effects: bradycardia, cardio-respiratory arrest.

5126853-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased
on Aug 24, 2006 Female patient from UNITED KINGDOM , 48 years of age, weighting 132.3 lb, was diagnosed with subarachnoid haemorrhage, prophylaxis against gastrointestinal ulcer, gastric hypomotility, lower respiratory tract infection, constipation prophylaxis and was treated with Nimotop (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased. Nimotop dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METOCLOPRAMIDE (Total Daily Dose: 30 Mg) (View Metoclopramide Review and Metoclopramide Label ), CEFTRIAXONE (Total Daily Dose: 2 G) (View Ceftriaxone Review and Ceftriaxone Label ), LACTULOSE (Total Daily Dose: 20 Ml) (View Lactulose Review and Lactulose Label ), SENNA (View Senna Review and Senna Label ), ACETAMINOPHEN (Total Daily Dose: 4 G) (View Acetaminophen Review and Acetaminophen Label ), PROPOFOL (View Propofol Review and Propofol Label ).

5122779-6 | Dermatitis Bullous, Erythema, Rash Pustular
on Jul 17, 2006 Female patient from FRANCE , 45 years of age, was diagnosed with unevaluable event, vascular test, therapeutic embolisation and was treated with Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: dermatitis bullous, erythema, rash pustular. Nimotop dosage: . During the same period patient was treated with IOMERON 150 (View Iomeron-150 Review and Iomeron-150 Label ), VISIPAQUE (View Visipaque Review and Visipaque Label ), DEPAKENE (View Depakene Review and Depakene Label ), ACUPAN (View Acupan Review and Acupan Label ), MORPHINE (View Morphine Review and Morphine Label ), HEPARIN (View Heparin Review and Heparin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), ORGARAN (View Orgaran Review and Orgaran Label ). Patient was hospitalized.

5071359-X | Dermatitis Bullous, Erythema, Rash Pustular
Patient was taking Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous, erythema, rash pustular on Jul 17, 2006 from FRANCE Additional patient health information: Female patient , 45 years of age, was diagnosed with unevaluable event, vascular test, therapeutic embolisation and. Nimotop dosage: . During the same period patient was treated with IOMERON 150 (View Iomeron-150 Review and Iomeron-150 Label ), VISIPAQUE (View Visipaque Review and Visipaque Label ), DEPAKENE (View Depakene Review and Depakene Label ), ACUPAN (View Acupan Review and Acupan Label ), MORPHINE (View Morphine Review and Morphine Label ), HEPARIN (View Heparin Review and Heparin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), ORGARAN (View Orgaran Review and Orgaran Label ). Patient was hospitalized.

5066118-8 | Hydrocephalus, Meningorrhagia, Ruptured Cerebral Aneurysm
Adverse event was reported on Jul 17, 2006 by a Female patient taking Nimotop (View Usage) (Dosage: Intravenous) was diagnosed with angiogram, therapeutic embolisation and. Location: FRANCE , 45 years of age, Patient had the following side effects: hydrocephalus (What is hydrocephalus?), meningorrhagia, ruptured cerebral aneurysm. During the same period patient was treated with IOMERON (IOMEPROL) (80 Ml, Total Daily, Intravenous) (View Iomeron (iomeprol) Review and Iomeron (iomeprol) Label ), VISIPAQUE (150 Ml, Total Daily, Intravenous) (View Visipaque Review and Visipaque Label ), DEPAKENE (Intravenous) (View Depakene Review and Depakene Label ), MORPHINE (View Morphine Review and Morphine Label ), HEPARIN (View Heparin Review and Heparin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), ORGARAN (View Orgaran Review and Orgaran Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

4910034-6 | Agranulocytosis, Laboratory Test Abnormal, Rash
on Jan 24, 2006 Male patient from FRANCE , 53 years of age, was diagnosed with prophylaxis, vasospasm, meningitis bacterial, urinary tract obstruction and was treated with Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: agranulocytosis, laboratory test abnormal, rash (What is rash?). Nimotop dosage: 30 Mg, Q4hr, Oral. During the same period patient was treated with CLAFORIN (CEFOTAXIME SODIUM) (4 G, Tid, Intravenous) (View Claforin (cefotaxime Sodium) Review and Claforin (cefotaxime Sodium) Label ), XATRAL (ALFUZOSIN) (5 Mg, Qd, Oral) (View Xatral (alfuzosin) Review and Xatral (alfuzosin) Label ), FRAGMIN (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

4778929-4 | Catheter Related Complication, Nervous System Disorder, Post Procedural Complication, Vasospasm
on Mar 21, 2005 Male patient from BELGIUM , 59 years of age, weighting 180.8 lb, was diagnosed with aneurysm (What is aneurysm?), subarachnoid haemorrhage and was treated with Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: catheter related complication, nervous system disorder, post procedural complication, vasospasm. Nimotop dosage: 10 Ml, Q1hr, Intravenous. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), ZANTAC (View Zantac Review and Zantac Label ), FRAXIPARINE (View Fraxiparine Review and Fraxiparine Label ).

4778787-8 | Catheter Related Complication
Patient was taking Nimotop (View Usage). Patient had the following side effects: catheter related complication on Mar 21, 2005 from BELGIUM Additional patient health information: Female patient , 46 years of age, was diagnosed with subarachnoid haemorrhage and. Nimotop dosage: 10 Ml, Q1hr, Intravenous. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), VALIUM (View Valium Review and Valium Label ), POLYIONIC GLUCOSE (View Polyionic Glucose Review and Polyionic Glucose Label ), ZANTAC (View Zantac Review and Zantac Label ).

4778784-2 | Catheter Related Complication
Adverse event was reported on Mar 21, 2005 by a Female patient taking Nimotop (View Usage) (Dosage: 10 Ml, Q1hr, Intravenous) was diagnosed with aneurysm (What is aneurysm?), subarachnoid haemorrhage and. Location: BELGIUM , 45 years of age, weighting 154.3 lb, After Nimotop was administered, patient had the following side effects: catheter related complication. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DIPHANTOINE (View Diphantoine Review and Diphantoine Label ), POLYIONIC GLUCOSE (View Polyionic Glucose Review and Polyionic Glucose Label ).

4778783-0 | Catheter Related Complication, Neurological Symptom, Post Procedural Complication, Vasospasm
on Mar 21, 2005 Male patient from BELGIUM , 53 years of age, weighting 180.8 lb, was diagnosed with aneurysm (What is aneurysm?), subarachnoid haemorrhage and was treated with Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: catheter related complication, neurological symptom, post procedural complication, vasospasm. Nimotop dosage: 10 Ml, Q1hr, Intravenous. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), ZANTAC (View Zantac Review and Zantac Label ), FRAXIPARINE (View Fraxiparine Review and Fraxiparine Label ).

4772913-2 | Catheter Related Complication
on Mar 21, 2005 Male patient from BELGIUM , 58 years of age, was diagnosed with subarachnoid haemorrhage and was treated with Nimotop (View Usage). Patient had the following side effects: catheter related complication. Nimotop dosage: 10 Ml, Q1hr, Intravenous. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), VALIUM (View Valium Review and Valium Label ), ZANTAC (View Zantac Review and Zantac Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), PLASMA LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER (View Plasma-lyte 56 And Dextrose 5% In Plastic Container Review and Plasma-lyte 56 And Dextrose 5% In Plastic Container Label ).

4745249-3 | Granulocytopenia
Patient was taking Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: granulocytopenia on Aug 04, 2005 from SPAIN Additional patient health information: Male patient , 41 years of age, weighting 176.4 lb, was diagnosed with peripheral vascular disorder, convulsion and. Nimotop dosage: 90 Mg, Total Daily, Oral. During the same period patient was treated with NEOSIDANTOINA (PHENYTOIN SODIUM) (300 Mg, Total Daily, Oral) (View Neosidantoina (phenytoin Sodium) Review and Neosidantoina (phenytoin Sodium) Label ). Patient was hospitalized.

4704372-X | Agranulocytosis, Rash, Spinal Myelogram Abnormal
Adverse event was reported on Jun 17, 2005 by a Male patient taking Nimotop (View Usage) (Dosage: ) . Location: , 53 years of age, Patient experienced the following unwanted or unexpected effects: agranulocytosis, rash (What is rash?), spinal myelogram abnormal. During the same period patient was treated with CLAFORAN (View Claforan Review and Claforan Label ), XATRAL (ALFUZOSIN) (5 Mg, Qd, Oral) (View Xatral (alfuzosin) Review and Xatral (alfuzosin) Label ), FRAGMIN (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

4638427-5 | Catheter Related Complication
on Mar 21, 2005 Male patient from , 58 years of age, was diagnosed with subarachnoid haemorrhage and was treated with Nimotop (View Usage). Patient had the following side effects: catheter related complication. Nimotop dosage: 10 Ml, Q1hr, Intravenous. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), VALIUM (View Valium Review and Valium Label ), ZANTAC (View Zantac Review and Zantac Label ), CONTRAMAL (View Contramal Review and Contramal Label ), PLASMA LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER (View Plasma-lyte 56 And Dextrose 5% In Plastic Container Review and Plasma-lyte 56 And Dextrose 5% In Plastic Container Label ).

4638426-3 | Catheter Related Complication
on Mar 21, 2005 Male patient from , 76 years of age, weighting 176.4 lb, was diagnosed with subarachnoid haemorrhage and was treated with Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: catheter related complication. Nimotop dosage: 10 Ml, Q1hr, Intravenous. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), CORVATON (View Corvaton Review and Corvaton Label ), ZANTAC (View Zantac Review and Zantac Label ).

4638424-X | Catheter Related Complication, Nervous System Disorder, Post Procedural Complication, Vasospasm
Patient was taking Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: catheter related complication, nervous system disorder, post procedural complication, vasospasm on Mar 21, 2005 from Additional patient health information: Male patient , 53 years of age, weighting 180.8 lb, was diagnosed with aneurysm (What is aneurysm?), subarachnoid haemorrhage and. Nimotop dosage: 10 Ml, Q1hr , Intravenous. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), ZANTAC (View Zantac Review and Zantac Label ), FRAXIPARINE (View Fraxiparine Review and Fraxiparine Label ).

4638413-5 | Catheter Related Complication
Adverse event was reported on Mar 21, 2005 by a Female patient taking Nimotop (View Usage) (Dosage: 10 Ml, Q1hr, Intravenous) was diagnosed with aneurysm (What is aneurysm?), subarachnoid haemorrhage and. Location: , 45 years of age, weighting 154.3 lb, Patient had the following side effects: catheter related complication. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DIPHANTOINE (View Diphantoine Review and Diphantoine Label ), POLYIONIC GLUCOSE (View Polyionic Glucose Review and Polyionic Glucose Label ).

4638411-1 | Catheter Related Complication
on Mar 21, 2005 Female patient from , 46 years of age, was diagnosed with subarachnoid haemorrhage and was treated with Nimotop (View Usage). After Nimotop was administered, patient had the following side effects: catheter related complication. Nimotop dosage: 10 Ml, Q1hr, Intravenous. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), VALIUM (View Valium Review and Valium Label ), POLYIONIC GLUCOSE (View Polyionic Glucose Review and Polyionic Glucose Label ), ZANTAC (View Zantac Review and Zantac Label ).

4596344-3 | Catheter Related Complication, Nervous System Disorder, Post Procedural Complication, Vasospasm
on Feb 17, 2005 Male patient from , 53 years of age, weighting 180.8 lb, was diagnosed with aneurysm (What is aneurysm?), subarachnoid haemorrhage and was treated with Nimotop (View Usage). Patient experienced the following unwanted or unexpected effects: catheter related complication, nervous system disorder, post procedural complication, vasospasm. Nimotop dosage: 10 Ml, Q1hr, Intravenous. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), ZANTAC (View Zantac Review and Zantac Label ), FRAXIPARINE (View Fraxiparine Review and Fraxiparine Label ).

4596099-2 | Catheter Related Complication
Patient was taking Nimotop (View Usage). Patient had the following side effects: catheter related complication on Feb 17, 2005 from Additional patient health information: Female patient , 45 years of age, weighting 154.3 lb, was diagnosed with aneurysm (What is aneurysm?), subarachnoid haemorrhage and. Nimotop dosage: 10 Ml, Q1hr, Intravenous. During the same period patient was treated with PERFUSALGAN (View Perfusalgan Review and Perfusalgan Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DIPHANTOINE (View Diphantoine Review and Diphantoine Label ), POLYIONIC GLUCOSE (View Polyionic Glucose Review and Polyionic Glucose Label ).